---
title: "NHS National Generics Pharmaceuticals - Supply Chain Resilience"
ocid: "ocds-h6vhtk-060abf"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-060abf"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-060abf.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-060abf.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2026-05-01"
---

# NHS National Generics Pharmaceuticals - Supply Chain Resilience

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-060abf

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-060abf)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-060abf.json)

## Summary

The procurement process titled "NHS National Generics Pharmaceuticals - Supply Chain Resilience" was initiated by NHS England, a central government public authority headquartered in London. This open procurement aims to establish a framework agreement for pharmaceutical products, specifically targeting supply chain resilience for generic medication. The procurement is divided into two lots: Oral (non-parenteral) products and Hospital-Only products, with regions including the Midlands, Southwest, Northwest, and various London sectors. The overall framework agreement is set to commence on 1 September 2026, with the possibility for call-offs extending until 31 May 2028. The tender stage was completed on 1 May 2026, and the contracts are scheduled to start on 1 September 2026. Bid submissions were open until 6 March 2026, according to the latest tender update.

This procurement offers significant opportunities for suppliers in the pharmaceutical industry, particularly those focusing on generic products. Large enterprises and SMEs alike can benefit, with numerous suppliers already awarded, including major companies like Fresenius Kabi Limited and Jannsen-Cilag Limited. The framework’s substantial scope and financial size can facilitate expanded market reach and increased contract opportunities. Businesses with capabilities to supply oral and hospital-only pharmaceutical products, interested in enhancing supply chain resilience in the UK health sector, are well-suited to participate in this framework agreement. The process encourages competition, and future call-offs provide ongoing business development potential for bidders adhering to the strict compliance and quality standards set by NHS England.

## Notice

NHS National Generics Pharmaceuticals - Supply Chain Resilience Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/25/5739/01 - Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months) NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months) LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months) CM/PHG/25/5739/02 - Hospital Only Products DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months) DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months) DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months) This tender is for lines that have recently been terminated or unable to be awarded on previous tenders. Please note we have previously referred to these as "Housekeeping" tenders.

### Lot Information

Lot 1 - CM/PHG/25/5739/01 - Oral (plus non-parenteral) products

CM/PHG/25/5739/01 - Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months) NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months) LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)

Options: Option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

Renewal: Option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

Lot 2 - CM/PHG/25/5739/02 - Hospital only products

CM/PHG/25/5739/02 - Hospital Only Products DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months) DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months) DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)

Options: Option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

Renewal: Option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

### Planning Information

NHS England is advising suppliers of an upcoming tender for the NHS National Generics Pharmaceuticals - Supply Chain Resilience, to commence on 1st September 2026 for varying dates of up to 21 months with options to extend for a maximum total contract period of 48 months. This procurement will largely consist of previously terminated products of hospital only and oral (plus non-parenteral) products across all regions of the country. The purpose of this notice is to inform existing and potential new suppliers of this procurement. Useful information for suppliers can be found here www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ . Specific information regarding the products included in this procurement will be provided in the ITO which will be issued shortly.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/040594-2026 |
| Notice type | UK6 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | SME |
| Awardee scale | Large, SME |
| All stages | Planning, Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 1 May 2026 |
| Submission deadline | 6 Mar 2026 |
| Future notice date | 30 Jan 2026 |
| Award date | 30 Apr 2026 |
| Contract period | 31 Aug 2026 - 31 May 2028 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £52,447,296 |
| Lots value | £52,447,296 |
| Awards value | £39,223,496 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Pending |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LONDON |
| Post town | South East London |
| Postcode | SE1 8UG |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI45 Lambeth |
| Local authority | Lambeth |
| Electoral ward | Waterloo & South Bank |
| Westminster constituency | Vauxhall and Camberwell Green |
| Delivery location | TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England) |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 26 |
| Supplier names | ACCORD; AMAROX; ASCEND LABORATORIES; ASPIRE PHARMA; BAXTER HEALTHCARE; BROWN AND BURK; CIPLA (EU; COLONIS PHARMA; CRESCENT PHARMA; DAY LEWIS MEDICAL; ENNOGEN HEALTHCARE INTERNATIONAL; FRESENIUS KABI; G.L. PHARMA; GLENMARK PHARMACEUTICALS (EUROPE; HIKMA PHARMACEUTICALS INTERNATIONAL; JANNSEN-CILAG; MACARTHYS LABORATORIES; MILPHARM; MORNINGSIDE PHARMACEUTICALS; NORTHUMBRIA PHARMA; SELECTIVE SUPPLIES; SUN PHARMA; TEVA; VIATRIS UK HEALTHCARE; WOCKHARDT; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 1 May 2026 at 13:38 - Award - UK6 - Contract Award Notice - https://www.find-tender.service.gov.uk/Notice/040594-2026
- 26 Feb 2026 at 15:25 - TenderUpdate - UK4 - Tender Notice - https://www.find-tender.service.gov.uk/Notice/017481-2026
- 30 Jan 2026 at 11:36 - TenderUpdate - UK4 - Tender Notice - https://www.find-tender.service.gov.uk/Notice/008379-2026
- 30 Jan 2026 at 10:15 - Tender - UK4 - Tender Notice - https://www.find-tender.service.gov.uk/Notice/008328-2026
- 21 Jan 2026 at 10:56 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/005168-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/040594-2026
  1st May 2026 - Contract award notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/017481-2026
  26th February 2026 - Tender notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/008379-2026
  30th January 2026 - Tender notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/008328-2026
  30th January 2026 - Tender notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/005168-2026
  21st January 2026 - Preliminary market engagement notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11220
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12671

## Notice URLs

- https://health-family.force.com/s/Welcome
- https://www.england.nhs.uk/
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-060abf. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-060abf.json.